Physician

Ahmed Abdul Azim, M.D.

According to 2025 Medicare claims, Ahmed Azim, M.D. (NPI: 1073922324) practices infectious disease in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (NPI: 1356385710; TIN: 223371727) and primary practice location at 08901-1928. Azim is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Azim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 121 traditional Medicare patients, billed 358 HCPCS/CPT codes, and received $30,981 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 248 prescription claims across 31 beneficiaries totaling $531,442 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,872 to $531,442. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$24K$48K2020 Medicare payment: $7,091 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $48,198 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $31,001 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $29,218 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $30,981 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20204370$7,091
2021219494$48,198
2022144358$31,001
2023113307$29,218
2024121358$30,981

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$266K$531K2015 Drug cost: $4,872 (USD; Tot_Drug_Cst)2016 Drug cost: $10,970 (USD; Tot_Drug_Cst)2017 Drug cost: $7,696 (USD; Tot_Drug_Cst)2018 Drug cost: $120,909 (USD; Tot_Drug_Cst)2019 Drug cost: $75,002 (USD; Tot_Drug_Cst)2021 Drug cost: $45,336 (USD; Tot_Drug_Cst)2022 Drug cost: $331,585 (USD; Tot_Drug_Cst)2023 Drug cost: $439,955 (USD; Tot_Drug_Cst)2024 Drug cost: $531,442 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201551125$4,872
20163980$10,970
20173177$7,696
201814104$120,909
2019N/R70$75,002
2020N/RN/RN/R
20211540$45,336
202221131$331,585
202330179$439,955
202431248$531,442

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes4344$136
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1515$110
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1829$92
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes58113$89
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes5393$62

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BiktarvyBictegrav/Emtricit/Tenofov Ala521,680$218,733
DovatoDolutegravir Sodium/Lamivudine371,170$112,266
TriumeqAbacavir/Dolutegravir/Lamivudi11330$38,834
PrezcobixDarunavir/Cobicistat14420$32,283
DarunavirDarunavir11330$4,668

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Ahmed Abdul Azim, M.D.?

Tedicare shows public-source Medicare data for Ahmed Abdul Azim, M.D. (NPI 1073922324), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Abdul Azim, M.D. have ACO affiliation data?

Ahmed Abdul Azim, M.D. is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Ahmed Abdul Azim, M.D.?

Ahmed Abdul Azim, M.D. is linked to RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (billing NPI 1356385710) in the available physician profile data.

Does Ahmed Abdul Azim, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.